Trader Talk
![]()
- Spring Home Buying Season: Good, But Not Good Enough?
- Where’s the French?
- Do the Europeans Really Want a Deal With Greece?
- Draghi’s Kiss: Putting a Bow On the Greek Bailout
- Brinksmanship: Is the EU Negotiating With the Wrong Parties?
- An Escrow Deal for Greece, or Just a Private Sector Deal?
- Housing Stocks Hit New Highs—Too Much Optimism?
- Still No Certainty on Greece, but the Chinese Help
- Greek Debt Drama: Current Act Is Ending
- More Greek Deadlines Today and Tomorrow
TRADER TALK RSS FEED
MOST SHARED
- RBS Hurt by Greek Charges But Pays Bonuses
- China Internet Firm Qihoo Says Citron Allegations False
- T-Mobile USA Wants to Grow Again
- European Shares Rise; Natixis, RBS Up on Results
- Nissan to Recall 250,000 Cars Globally
- German February IFO Index Rises 4th Month in Row
- More Asset-Buying Depends on Economy: Bank of England
- Greek Writedown Hits Commerzbank Earnings
- Japan's Okada Says Yen Still Strong, Hopes it Weakens
- Herbalife Shares Gain on Obesity Play
- Wandering Through Toy Land
- Dell Is Done, But Don't Discount HP: Analysts
- Comcast Deal Could Spell Trouble for Netflix: Analyst
- Reading the Tea Leaves in RIM Shake-Up
- Sam Adams Brewer Crafts Beer for the Granddaddy of All Marathons
- Stocks to Give Up for Lent
- You Want Retail Customers? Give Them Deals: Analysts
- NJ Governor Chris Christie to Warren Buffett: 'Just Write a Check and Shut Up'
- 7 Undervalued IPO Stocks That Could Rebound in 2012
- Winners and Losers in Obama's Corporate Tax Plan
- More Asset-Buying Depends on Economy: BOE
- Greece Readies Debt Swap Under Bailout Deal
- Stocks Sputter as Investors Seek Next Catalyst
- RBS Hurt by Greek Charges But Pays Bonuses
- Nissan to Recall 250,000 Cars Globally
- T-Mobile USA Wants to Grow Again
- Greek Writedown Hits Commerzbank Earnings
- Chinese Court Says Apple Can Sell iPads in Shanghai
What Really Sunk NYSE Deal?
CNBC Reporter
NYSE Euronext CEO Duncan Niederauer's comment in Davos that there was only a "glimmer of hope" on the NYSE Euronext-Deutsche Boerse deal is a blunt recognition that the deal was sunk by a combination of a euro crisis that has engulfed the continent, and furious lobbying by euro banks whose derivatives business might be hurt by the deal.
![]() |
Getty Images |
The NYSE [NYSE
Loading...
()
] has focused its lobbying efforts on Germany, trying to convince them that the deal would make Frankfurt the global capital of capital raising and that it would afford the Germans — and the rest of Europe — more regulatory control over the industry.
Both are plausible — indeed powerful — arguments, and may have prevailed in normal times.
But these are not normal times.
In normal times, both entities could have likely counted on support from Germany's Angela Merkel. But something happened between now and when the deal was inked last February: the euro crisis.
Merkel is simply too overwhelmed to make this much of a focus.
Other allies are also out: Christine Lagarde, French Finance Minister when the deal was signed, was a likely supporter but is now IMF head.
What sunk the deal? Besides the euro crisis, blame the banks. The EU competition commissioner insisted that the combined entity would have a monopoly on derivative trading and refused to acknowledge that over the counter trading (OTC) is a huge part of the business.
Who does OTC trading of derivatives? Banks. It's an opaque business with little transparency that's very profitable. The merger is a direct threat to their business. They lobbied furiously to stop this deal.
What's next? Transnational stock exchange mergers look dead. First LSE-Toronto fails, then Australia-Singapore. Now NYSE-DB.
Instead look for more modest hookups. A reset from megamergers to joint ventures and partnerships in technology services and clearing, for example. NYSE needs more clearing capabilities. LCH in London, which is 9 percent owned by NYSE, is in play now.
One big problem: who wants to be in the stock business? It's not very appealing, what with the lousy margins and appalling lack of volume.
That's why CME and ICE are not as appealing merger partners as many keep thinking. It's likely neither one wants the stock business. CME would keep LIFFE (the derivatives business), and sell off everything else. Huh? Some merger that would be.
One last point: don't look for a vote count. This is the EU after all. Officially 27 EU commissioners will vote on the deal in early February, where a majority vote is needed. But these votes almost invariably proceed on consensus and no vote is ever announced.
_____________________________
Bookmark CNBC Data Pages:
_____________________________
Want updates whenever a Trader Talk blog is filed? Follow me on Twitter: twitter.com/BobPisani.
Questions? Comments?
- The economy is heating up but the Fed isn’t letting up. How do you play the fixed-income market?
- With its rich oil reserves and rampant corruption, Azerbaijan poses a dilemma for U.S. policy makers.
- Business owners should occasionally consider giving their work for free. Here are several reasons why.
- GOP Governor Chris Christie wants Warren Buffett to stop talking about higher taxes on the super-rich.
- There’s a shortage of hotel rooms in London for the Olympics, so many locals are renting out their opulent private homes.
- Boston Beer will be creating a special commemorative brew, the Samuel Adams Boston 26.2, to mark this year's Boston Marathon.
- Spring Home Buying Season: Good, But Not Good Enough?
- Where’s the French?
- Do the Europeans Really Want a Deal With Greece?
- Draghi’s Kiss: Putting a Bow On the Greek Bailout
- Brinksmanship: Is the EU Negotiating With the Wrong Parties?
- An Escrow Deal for Greece, or Just a Private Sector Deal?
- Housing Stocks Hit New Highs—Too Much Optimism?
- Still No Certainty on Greece, but the Chinese Help
- Greek Debt Drama: Current Act Is Ending
- More Greek Deadlines Today and Tomorrow












